AI Article Synopsis

  • The report discusses a multicenter, randomized controlled trial aimed at determining if targeted antimicrobial prophylaxis, based on rectal culture screening, can prevent acute bacterial prostatitis after transrectal prostate biopsy (TRPB).
  • Patients in the trial will be split into two groups: one receiving tailored antibiotics like tazobactam-piperacillin or levofloxacin, and the other receiving standard levofloxacin treatment.
  • The study's main goal is to measure the rate of acute bacterial prostatitis occurrences post-biopsy, with recruitment for the trial starting in April 2021 and a target of 5,100 participants.

Article Abstract

The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into an intervention or non-intervention group; tazobactam-piperacillin or levofloxacin will be prophylactically administered according to the results of rectal culture prior to TRPB in the intervention group whereas levofloxacin will be routinely given in the non-intervention group. The primary endpoint is the occurrence rate of acute bacterial prostatitis after TRPB. Recruitment begins in April, 2021 and the target total sample size is 5,100 participants.

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/62782DOI Listing

Publication Analysis

Top Keywords

tailored antimicrobial
8
antimicrobial prophylaxis
8
transrectal prostate
8
prostate biopsy
8
multicenter randomized
8
randomized controlled
8
controlled trial
8
rectal culture
8
acute bacterial
8
bacterial prostatitis
8

Similar Publications

Emphysematous pyelonephritis (EPN) is a urinary tract infection progression characterized by gas retention in the renal tissues and a high mortality rate, but few cases have been reported. In this study, we present a 32-year-old primigravida with type 2 diabetes mellitus and a history of pyelonephritis who developed pyelonephritis at 29 weeks. Antimicrobial therapy was initiated; however, her clinical symptoms worsened.

View Article and Find Full Text PDF

The rising incidence of fungal infections coupled with limited treatment options underscores the urgent need for novel antifungal therapies. Riboswitches, particularly thiamin pyrophosphate (TPP) class, have emerged as promising antimicrobial targets. This study presents a comprehensive genome-wide analysis of TPP riboswitches in 156 medically relevant fungi utilizing advanced covariance models (CMs) tailored for fungal sequences.

View Article and Find Full Text PDF

Antimicrobial resistance (AMR) poses risks for food stakeholders because of the spread of resistant microbes and potential foodborne diseases. In example, pigs may carry strains, which can infect humans through contaminated food preparations. Due to their antibacterial properties and capacity to modulate bacterial drug resistance, essential oils (EOs) are attracting interest as prospective substitutes for synthetic antimicrobials which can help to reverse microbial resistance.

View Article and Find Full Text PDF

Screening sites for detection of carbapenemase-producers- a retrospective cohort study.

Antimicrob Resist Infect Control

December 2024

Division of Infectious Diseases and Infection Control, Hospital Epidemiology, University Hospital Basel, University Basel, Petersgraben 4, CH-4031, Basel, Switzerland.

While screening the rectal site and urine may be appropriate for detection of carbapenemase-producing Enterobacterales, respiratory samples, throat and wound swabs may increase the sensitivity of screening protocols when aiming to detect colonization with carbapenemase-producing non-fermenting bacteria. Our results support the need for tailoring screening recommendations according to the bacterial species targeted.

View Article and Find Full Text PDF

Background: Idiopathic CD4+ T lymphocytopenia is a rare immune dysfunction disease that is usually found after opportunistic infections. Mycobacterium abscessus is a rapidly growing mycobacterium that can cause pulmonary infections, lymphadenitis, skin and soft tissue infections, disseminated infections, among others, as a conditional pathogenic bacterium.

Case Presentation: We present the case of a 43-year-old Chinese woman who developed disseminated Mycobacterium abscessus infection due to idiopathic CD4+ T lymphocytopenia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!